All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99


Pattern of Risk Factors of Cardioembolic Stroke in Dhamar Governorate Yemen

DOI: 10.4236/oalib.1110865, PP. 1-8

Subject Areas: Cardiology

Keywords: Stroke, Cardio-Embolism, Acute Cerebral Ischemia, Smoking, Shamma

Full-Text   Cite this paper   Add to My Lib


Stroke is a leading cause of mortality and disability in Yemen and around the world. Cardio-embolism is responsible for nearly 30% of the origins of ischemic stroke. Objective: The purpose of this study was to determine the incidence cardio-embolic subtype. Material and Methods: The current study was done on 77 hospitalized patients who admitted as case of cardio-embolic ischemic stroke in Thamar governorate, Yemen. Cross-sectional study been conducted in Al_Wahada Teaching 2021 and available cases in internal /hospital and Dhamar hospital in academic year 2021medicine department in A Lwahada hospital, Dhamar hospital and Arryadah Hospital during period of study. Results: Of the 77 patients, 44 (57.10%) were male patients, and 33 (43.90%) were female, hypertension were the most common cause of cardio-embolism corresponding to (54.50%) followed by acute coronary syndrome (11.7%) and cardiomyopathy (7.8%), arrhythmia (3.9%) and infective endocarditis (1.3%) were the most common risk factors. Conclusion: The risk of stroke increases with age. In this study, Hypertension, Smoking, Shamma, were the main causes of cardio-embolism.

Cite this paper

Mujlli, H. , Huthi, M. A. A. , Jaid, D. , Haj, E. H. A. , Ahmed, E. K. and Al-Barakani, H. (2023). Pattern of Risk Factors of Cardioembolic Stroke in Dhamar Governorate Yemen. Open Access Library Journal, 10, e865. doi:


[1]  Krishnamurthi, R.V., Feigin, V.L., Forouzanfar, M.H., Mensah, G.A., Connor, M., Bennett, D.A., Moran, A.E., Sacco, R.L., Anderson, L.M., Truelsen, T., O’Donnell, M., Venketasubramanian, N., Barker-Collo, S., Lawes, C.M., Wang, W., Shinohara, Y., Witt, E., Ezzati, M., Naghavi, M., Murray, C., Global Burden of Diseases IRFS and Group GBDSE (2013) Global and Regional Burden of First-ever Ischaemic and Haemorrhagic Stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010. The Lancet Global Health, 1, e259-e281.
[2]  Hart, R.G., Diener, H.C., Coutts, S.B., Easton, J.D., Granger, C.B., O’Donnell, M.J., Sacco, R.L. and Connolly, S.J. (2014) Cryptogenic Stroke/ESUS International Working Group. Embolic Strokes of Undetermined Source: The Case for a New Clinical Construct. The Lancet Neurology, 13, 429-438.
[3]  Nishimura, R.A., Otto, C.M., Bonow, R.O., Carabello, B.A., Erwin, J.P., Guyton, R.A., O’Gara, P.T., Ruiz, C.E., Skubas, N.J., Sorajja, P., Sundt, T.M. and Thomas, J.D. (2014) ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129, e521-e643.
[4]  Bogiatzi, C., Hackam, D.G., McLeod, A.I. and Spence, J.D. (2014) Secular Trends in Ischemic Stroke Subtypes and Stroke Risk Factors. Stroke, 45, 3208-3213.
[5]  Yiin, G.S., Howard, D.P., Paul, N.L., Li, L., Luengo-Fernandez, R., Bull, L.M., Welch, S.J., Gutnikov, S.A., Mehta, Z. and Rothwell, P.M. (2014) Oxford Vascular Study. Age-Specific Incidence, Outcome, Cost, and Projected Future Burden of Atrial Fibrillation-Related Embolic Vascular Events: A Population-Based Study. Circulation, 130, 1236-1244.
[6]  Chugh, S.S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E.J., Gillum, R.F., Kim, Y.H., McAnulty, J.H., Zheng, Z.J., Forouzanfar, M.H., Naghavi, M., Mensah, G.A., Ezzati, M. and Murray, C.J. (2014) Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation, 129, 837-847.
[7]  Wolf, P.A., Abbott, R.D. and Kannel, W.B. (1991) Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study. Stroke, 22, 983-988.
[8]  Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V. and Singer, D.E. (2001) Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 285, 2370-2375.
[9]  Ambrosy, A.P., Fonarow, G.C., Butler, J., Chioncel, O., Greene, S.J., Vaduganathan, M., Nodari, S., Lam, C.S., Sato, N., Shah, A.N. and Gheorghiade, M. (2014) The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned from Hospitalized Heart Failure Registries. Journal of the American College of Cardiology, 63, 1123-1133.
[10]  Chen, J., Normand, S.L., Wang, Y. and Krumholz, H.M. (2011) National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008. JAMA, 306, 1669-1678.
[11]  Blecker, S., Paul, M., Taksler, G., Ogedegbe, G. and Katz, S. (2013) Heart Failure—Associated Hospitalizations in the United States. Journal of the American College of Cardiology, 61, 1259-1267.
[12]  Lip, G.Y. and Gibbs, C.R. (1999) Does Heart Failure Confer a Hypercoagulable State? Virchow’s Triad Revisited. Journal of the American College of Cardiology, 33, 1424-1426.
[13]  Amarenco, P., Davis, S., Jones, E.F., Cohen, A.A., Heiss, W.D., Kaste, M., Laouénan, C., Young, D., Macleod, M. and Donnan, G.A. (2014) Aortic Arch Related Cerebral Hazard Trial Investigators. Clopidogrel plus Aspirin versus Warfarin in Patients with Stroke and Aortic Arch Plaques. Stroke, 45, 1248-1257.
[14]  Benavente, O.R., Hart, R.G., McClure, L.A., Szychowski, J.M., Coffey, C.S. and Pearce, L.A. (2012) Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke. The New England Journal of Medicine, 367, 817-825.


comments powered by Disqus

Contact Us


WhatsApp +8615387084133

WeChat 1538708413